Glucagon Like Peptide-1-Induced Glucose Metabolism in Differentiated Human Muscle Satellite Cells Is Attenuated by Hyperglycemia
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Glucagon like peptide-1 (GLP-1) stimulates insulin secretion from the pancreas but also has extra-pancreatic effects. GLP-1 may stimulate glucose uptake in cultured muscle cells but the mechanism is not clearly defined. Furthermore, while the pancreatic effects of GLP-1 are glucose-dependent, the glucose-dependency of its extra-pancreatic effects has not been examined. METHODS: Skeletal muscle satellite cells isolated from young (22.5 ± 0.97 yr), lean (BMI 22.5 ± 0.6 kg/m(2)), healthy males were differentiated in media containing either 22.5 mM (high) or 5 mM (normal) glucose for 7 days in the absence or presence of insulin and/or various GLP-1 concentrations. Myocellular effects of GLP-1, insulin and glucose were assessed by western-blot, glucose uptake and glycogen synthesis. RESULTS: We firstly show that the GLP-1 receptor protein is expressed in differentiated human muscle satellite cells (myocytes). Secondly, we show that in 5 mM glucose media, exposure of myocytes to GLP-1 results in a dose dependent increase in glucose uptake, GLUT4 amount and subsequently glycogen synthesis in a PI3K dependent manner, independent of the insulin signaling cascade. Importantly, we provide evidence that differentiation of human satellite cells in hyperglycemic (22.5 mM glucose) conditions increases GLUT1 expression, and renders the cells insulin resistant and interestingly GLP-1 resistant in terms of glucose uptake and glycogen synthesis. Hyperglycemic conditions did not affect the ability of insulin to phosphorylate downstream targets, PKB or GSK3. Interestingly we show that at 5 mM glucose, GLP-1 increases GLUT4 protein levels and that this effect is abolished by hyperglycemia. CONCLUSIONS: GLP-1 increases glucose uptake and glycogen synthesis into fully-differentiated human satellite cells in a PI3-K dependent mechanism potentially through increased GLUT4 protein levels. The latter occurs independently of the insulin signaling pathway. Attenuation of both GLP-1 and insulin-induced glucose metabolism by hyperglycemia is likely to occur downstream of PI3K.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5 Effect of GLP-1 treatment on glycogen synthesis in myocytes cultured in high or normal glucose media. Satellite cells were isolated from lean, healthy males (n = 6), and differentiated in either high glucose (22 mM, open bars) or normal glucose (5 mM, black bars) media for seven days. Myocytes were treated with either 100 nM insulin and/or 100 nM GLP-1 for 30 minutes before assessing glycogen synthesis (by measuring incorporation of [14C]-glucose in to glycogen). (A) Shows absolute rates of glycogen synthesis in the basal level (n = 6, in triplicate); (B) indicates fold changes from basal levels for each glucose condition. Significant changes from basal levels are indicated by * (P<0.05), and ** (P<0.001).](https://figures.cochat.ai/paper-figures/e3522dd307874d039d601f5d7319c0c2/glucagon-like-peptide-1-induced-glucose-metabolism-in-differentiated-human-figure-5.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The notable advantage for muscle preservation seems to be the use of glucagon-like peptide-1 (GLP-1) receptor agonists34,35 and dipeptidyl peptidase-4 inhibitors (DPP-4i),36–38 which not only minimally affects muscle mass loss but also stimulates muscle contraction and aid in muscle recovery.”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 1×
“Protein concentrations were determined using the Bradford reagent [20].”
MethodHidaka, H., Inagaki, M., Kawamoto, S., & Sasaki, Y. (1984) · Biochemistry · doi:10.1021/bi00316a032 · Cited by 2,687 · cited 1×
“7 mM and PKC = 6 mM) [14] which suppressed GLP-1 mediated glucose transport [10].”
BackgroundSkeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102 · cited 1×
“Similarly, in hyperglycemic individuals skeletal muscle insulin sensitivity of glucose uptake is also poor [16].”
BackgroundA role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950 · cited 1×
“Peripherally, GLP-1 is known to affect gut motility [2,3], and centrally GLP-1 induces satiety [4,5].”
BackgroundMicroRNAs 103 and 107 regulate insulin sensitivity
Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M. (2011) · Nature · doi:10.1038/nature10112 · Cited by 1,000 · cited 1×
“(miRNAs) in diabetic [41] and obese [42] rats resulting in”
BackgroundRates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans
Baron, A. D., Brechtel, G., Wallace, P., & Edelman, S. V. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.6.e769 · Cited by 642 · cited 1×
“Increased non-insulin-dependent glucose disposal under hyperglycemic conditions has also been observed in vivo at the whole body level [36].”
BackgroundGutzwiller, J.-P., Drewe, J., Göke, B., Schmidt, H., Rohrer, B., Lareida, J., & Beglinger, C. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.5.r1541 · Cited by 521
The incretin system and its role in type 2 diabetes mellitus
HOLST, J., VILSBOLL, T., & DEACON, C. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.012 · Cited by 515 · cited 1×
“type 2 diabetics), GLP-1 stimulation of insulin is poor [15].”
BackgroundXia, P., Inoguchi, T., Kern, T. S., Engerman, R. L., Oates, P. J., & King, G. L. (1994) · Diabetes · doi:10.2337/diab.43.9.1122 · Cited by 477 · cited 1×
“In line with this hyperglycemia promotes de novo DAG synthesis through the phosphatidic acid pathway [33] leading to cross talk between PKC and PI3K [34].”
BackgroundButeau, J., Roduit, R., Susini, S., & Prentki, M. (1999) · Diabetologia · doi:10.1007/s001250051238 · Cited by 413 · cited 3×
“Furthermore, inhibition of PI3K led to suppressed DNA synthesis by GLP-1 in INS-1 cells [27].”
Background
Cited by
Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function
Frampton, J., Murphy, K. G., Frost, G., & Chambers, E. S. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0188-7 · Cited by 516
Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Rowlands, J., Heng, J., Newsholme, P., & Carlessi, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00672 · Cited by 302
Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
Oh, Y., & Jun, H.-S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010026 · Cited by 217
“In addition to its actions on the pancreas, GLP-1 reduces glucose production in the liver and increases glucose uptake in adipose tissue and muscle [64,78,79].”
BackgroundAmelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
Hong, Y., Lee, J. H., Jeong, K. W., Choi, C. S., & Jun, H. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12434 · Cited by 188
Efficacy of increased resistant starch consumption in human type 2 diabetes
Bodinham, C. L., Smith, L., Thomas, E. L., Bell, J. D., Swann, J. R., Costabile, A., Russell-Jones, D., Umpleby, A. M., & Robertson, M. D. (2014) · Endocrine Connections · doi:10.1530/ec-14-0036 · Cited by 137
“GLP1 has been shown to directly increase muscle glucose uptake in rodent models (25), with the GLP1 receptor recently localized to human skeletal muscle (26).”
Sayed, N. H., Fathy, N., Kortam, M. A., Rabie, M. A., Mohamed, A. F., & Kamel, A. S. E. D. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00805-5 · Cited by 146
“WM significantly attenuated GLP-1-mediated increase in GLUT4 protein level [74].”
BackgroundPerna, S., Guido, D., Bologna, C., Solerte, S. B., Guerriero, F., Isu, A., & Rondanelli, M. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0525-y · Cited by 125
“An alternative explanation could be based on the increased linkage GLP-1 and GLUT4 gene expression [21].”
BackgroundMassimino, E., Izzo, A., Riccardi, G., & Della Pepa, G. (2021) · Cells · doi:10.3390/cells10081958 · Cited by 102
Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity
Yaribeygi, H., Sathyapalan, T., & Sahebkar, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116776 · Cited by 102
“GLUT-4 Expression/Localization Increase GLUT-4 expression/localization in insulin-dependent tissues [101-104]”
Andreozzi, F., Raciti, G. A., Nigro, C., Mannino, G. C., Procopio, T., Davalli, A. M., Beguinot, F., Sesti, G., Miele, C., & Folli, F. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0985-7 · Cited by 102
GLP-1 regulates exercise endurance and skeletal muscle remodeling via GLP-1R/AMPK pathway
Wu, L., Zhou, M., Li, T., Dong, N., Yi, L., Zhang, Q., & Mi, M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119300 · Cited by 101
Malin, S. K., Haus, J. M., Solomon, T. P. J., Blaszczak, A., Kashyap, S. R., & Kirwan, J. P. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00441.2013 · Cited by 89
“Our data are also consistent with animal work and human muscle cell studies demonstrating that hyperglycemia downregulates glycogen synthase (10, 21).”
ResultSelf-citationGupta, P., Bala, M., Gupta, S. K., Dua, A., Dabur, R., Injeti, E. R., & Mittal, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.029 · Cited by 101
Role of brain-gut-muscle axis in human health and energy homeostasis
Yin, Y., Guo, Q., Zhou, X., Duan, Y., Yang, Y., Gong, S., Han, M., Liu, Y., Yang, Z., Chen, Q., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.947033 · Cited by 86
“GLP-1 also stimulates glucose uptake independent of PKB phosphorylation and promotes its storage independent of GSK3 phosphorylation (80).”
BackgroundSolomon, T. P. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00896 · Cited by 70
Self-citationGLP-1 increases microvascular recruitment but not glucose uptake in human and rat skeletal muscle
Sjøberg, K. A., Holst, J. J., Rattigan, S., Richter, E. A., & Kiens, B. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00283.2013 · Cited by 69
“In contrast to what has been published in cell culture (16) and recent rodent studies (4), we found no effect of GLP-1 on human leg glucose uptake even at supraphysiological concentrations.”
BackgroundResultBifari, F., Manfrini, R., Dei Cas, M., Berra, C., Siano, M., Zuin, M., Paroni, R., & Folli, F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.025 · Cited by 69
Ceriello, A., Novials, A., Ortega, E., Canivell, S., La Sala, L., Pujadas, G., Bucciarelli, L., Rondinelli, M., & Genovese, S. (2013) · Diabetes Care · doi:10.2337/dc13-0750 · Cited by 65
“These data, altogether, support the hypothesis that the endothelium, as in hyperglycemia (11,21,22), became less sensitive to GLP-1 in hypoglycemia, more than GLP-1 itself loses its activity, and that oxidative stress might be themediator of such phenomenon.”
ResultNausheen, S., Shah, I. H., Pezeshki, A., Sigalet, D. L., & Chelikani, P. K. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00130.2013 · Cited by 67
“Consistent with other studies on GLP-1-induced glucose uptake in muscle (4, 11, 26), our findings suggest that GLP-1 may signal through PKA and AMPK to increase glucose uptake via the insulin-sensitive GLUT4 in muscle and fat.”
ResultLi, Z., Ni, C.-L., Yao, Z., Chen, L.-M., & Niu, W.-Y. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.008 · Cited by 56
Marrano, N., Biondi, G., Borrelli, A., Cignarelli, A., Perrini, S., Laviola, L., Giorgino, F., & Natalicchio, A. (2021) · Biomolecules · doi:10.3390/biom11020286 · Cited by 56
Carter, S., & Solomon, T. P. J. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2210-4 · Cited by 74
Self-citationCutuli, D., Decandia, D., Giacovazzo, G., & Coccurello, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914686 · Cited by 64
“The GLP-1 receptor (GLP-1R) is expressed in many tissues, including the ENS, and in SM, where it participates in glycogen synthesis and in the potentiation of glucose uptake [171].”
BackgroundZhang, H., Liu, Y., Guan, S., Qu, D., Wang, L., Wang, X., Li, X., Zhou, S., Zhou, Y., Wang, N., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0148827 · Cited by 50
The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis
Yajima, T., Yajima, K., Takahashi, H., & Yasuda, K. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.018 · Cited by 45
Changes in insulin sensitivity and secretion after sleeve gastrectomy
Casella, G., Soricelli, E., Castagneto‐Gissey, L., Redler, A., Basso, N., & Mingrone, G. (2016) · British journal of surgery · doi:10.1002/bjs.10039 · Cited by 41
Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity
Ahlin, S., CEFALO, C. M. A., Bondia‐Pons, I., Capristo, E., Marini, L., Gastaldelli, A., Mingrone, G., & Nolan, J. J. (2019) · British journal of surgery · doi:10.1002/bjs.11208 · Cited by 41
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Devasia, A. G., Ramasamy, A., & Leo, C. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041778 · Cited by 48
“AKT activation is vital for the movement of GLUT4 vesicles to the cell surface, allowing glucose entry into cells [322,324].”
GLP‑1 improves palmitate‑induced insulin resistance in human skeletal muscle via SIRT1 activity
Jeon, J., Choi, S., Ha, E., Lee, H., Kim, T., Han, S., Kim, H., Kim, D., Kang, Y., & Lee, K. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4272 · Cited by 33
Direct effect of incretin hormones on glucose and glycerol metabolism and hemodynamics
Karstoft, K., Mortensen, S. P., Knudsen, S. H., & Solomon, T. P. J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00520.2014 · Cited by 32
“For example, GLP-1 receptors have been identified by us and others in rat/human skeletal muscle, in muscle cell lines and primary human muscle cells (10, 16, 40), in human adipose tissue (23), and in human hepatocytes (17), although this has recently been questioned (30).”
BackgroundSelf-citationExendin-4 increases oxygen consumption and thermogenic gene expression in muscle cells
Choung, J.-S., Lee, Y.-S., & Jun, H.-S. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0078 · Cited by 31
Current Nutritional and Pharmacological Approaches for Attenuating Sarcopenia
Sakuma, K., Hamada, K., Yamaguchi, A., & Aoi, W. (2023) · Cells · doi:10.3390/cells12192422 · Cited by 39
“For skeletal muscle, they increase GLUT4 gene expression, glucose uptake, and glycogen synthesis [87].”
BackgroundMechanisms for the cardiovascular effects of glucagon-like peptide-1
Poudyal, H. (2015) · Acta Physiologica · doi:10.1111/apha.12604 · Cited by 34
“…muscle satellite cells (myocytes), umbilical vein endothelial cells, adipose-derived stem cells during osteogenic differentiation and neuroprogenitor cell-derived neurones but not astrocytes or oligodendrocytes (Ding and Zhang, 2012, Green et al. 2012, Velmurugan et al. 2012, Jeon et al. 2014).”
BackgroundSjøberg, K. A., Rattigan, S., Jeppesen, J. F., Lundsgaard, A., Holst, J. J., & Kiens, B. (2015) · The Journal of Physiology · doi:10.1113/jp270129 · Cited by 27
“However, the GLP-1 receptor appears to be less abundant in intact skeletal muscle in humans (Green et al. 2012), dogs (Sandhu et al.”
BackgroundInfluentialGreen, C., Bunprajun, T., Pedersen, B. K., & Schéele, C. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.251421 · Cited by 29
“Additionally, we have also shown that satellite cells differentiated under hyperglycaemic conditions (22.5 mM) have significantly higher basal glucose uptake than satellite cells differentiated in normal glycaemic (5 mM) conditions (Green et al. 2012).”
BackgroundInfluentialSelf-citationIwase, Y., Kamei, N., & Takeda‐Morishita, M. (2015) · Pharmacology & Pharmacy · doi:10.4236/pp.2015.63020 · Cited by 29
“GLP-1 secretion increases the GLUT4 protein level in skeletal muscle or fat, which increases glucose uptake and glycogen synthesis [42].”
Aizawa, H., Yamada, S., Xiao, T., Shimane, T., Hayashi, K., Qi, F., Tanaka, H., & Kurita, H. (2017) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2017.08.014 · Cited by 23
Ceriello, A., Novials, A., Ortega, E., Canivell, S., Pujadas, G., Sala, L. L., Bucciarelli, L. G., Rondinelli, M., & Genovese, S. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-97 · Cited by 24
Transforming steatotic liver disease management: The emerging role of GLP-1 receptor agonists
Jensen, E., Israelsen, M. E., & Krag, A. A. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000561 · Cited by 25
The Effects of TNF-α on GLP-1-Stimulated Plasma Glucose Kinetics
Lehrskov, L. L., Lehrskov, L. L., Nielsen, S. T., Holst, J. J., Møller, K., & Solomon, T. P. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4244 · Cited by 21
Self-citationRuze, R., Xu, Q., Liu, G., Li, Y., Chen, W., Cheng, Z., Xiong, Y., Liu, S., Zhang, G., Hu, S., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00126.2021 · Cited by 20
Pujadas, G., Nigris, V. D., Sala, L. L., Testa, R., Genovese, S., & Ceriello, A. (2015) · Endocrine · doi:10.1007/s12020-015-0799-z · Cited by 17
“Using a cellular model of differentiated human muscle satellite cells exposed to HG, it is possible to observe a diminished GLP1r protein expression [17].”
BackgroundLiu, Y., Hu, Y., Ma, B., Wang, Z., & Wei, B. (2025) · Microbial Ecology · doi:10.1007/s00248-025-02529-w · Cited by 21
“Moreover, GLP-1 increases the uptake of glucose without dependence on PKB phosphorylation while increasing glucose storage without dependence on GSK3 phosphorylation [66].”
Incretin Therapy and Heart Failure
Oyama, J., & Node, K. (2014) · Circulation Journal · doi:10.1253/circj.cj-13-1561 · Cited by 15
Oral Treatment of Obesity by GLP-1 and Its Analogs
Holler, N., Ruseska, I., Schachner-Nedherer, A.-L., Zimmer, A., & Petschacher, C. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17121596 · Cited by 13
Shih, L.-C., Lin, R.-J., Chen, Y., & Fu, S. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-023-00587-w · Cited by 19
“These SCFA-mediated signalling pathways in skeletal muscles are involved in a range of physiological processes, such as triggering the release of glucagon-like peptide-1, leptin, and insulin in colons 65,66 and 67 , respectively.”
BackgroundNigris, V. D., Prattichizzo, F., Mancuso, E., Spiga, R., Pujadas, G., & Ceriello, A. (2017) · Oncotarget · doi:10.18632/oncotarget.22849 · Cited by 13
Imaging of Sarcopenia in Type 2 Diabetes Mellitus
Wang, D., Zhang, G., Yu, Y., & Zhang, Z. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s443572 · Cited by 11
“33 The notable advantage for muscle preservation seems to be the use of glucagon-like peptide-1 (GLP-1) receptor agonists 34,35 and dipeptidyl peptidase-4 inhibitors (DPP-4i), 36–38 which not only minimally affects muscle mass loss but also stimulates muscle contraction and aid in muscle recovery.”
BackgroundGLP-1 and Its Role in Glycogen Production: A Narrative Review
Lotosky, J., Jean, X., Altankhuyag, A., Khan, S. R., Bernotas, A., Sharafshah, A., Blum, K., Posner, A. R., & Thanos, P. K. (2025) · Biomedicines · doi:10.3390/biomedicines13071610 · Cited by 17
“PI3K induction by GLP-1 agonists, independent of insulin activity, potentially increases GLUT-4 protein levels [101].”
Targeting Sarcopenia in CKD: The Emerging Role of GLP-1 Receptor Agonists
Llinares-Arvelo, V., Martínez‐Alberto, C. E., González-Luis, A., Macía-Heras, M., Siverio-Morales, O., Navarro‐González, J. F., & Donate‐Correa, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168096 · Cited by 15
“Western blot analyses using lysates from differentiated human muscle satellite cells and skeletal muscle biopsies have detected a ~53 kDa band consistent with GLP-1R, with expression levels modulated by the extracellular glucose concentration during myogenic differentiation [112].”
Eshghi, S. R. T., Fletcher, K., Myette‐Côté, É., Durrer, C. G., Gabr, R. Q., Little, J. P., Senior, P. A., Steinback, C. D., Davenport, M. H., Bell, G. J., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00154 · Cited by 13
“The GLP-1 receptor has been found in cardiac muscle, smooth muscle of the vasculature, and perhaps skeletal muscle (16, 17).”
BackgroundMadsen, S. H., Bak, S. Y., Yde, C. C., Jensen, H. M., Knudsen, T. A., Bæch‐Laursen, C., Holst, J. J., Laustsen, C., & Hedemann, M. S. (2023) · Metabolites · doi:10.3390/metabo13090974 · Cited by 11
Chen, W., Qin, H., Zhou, Z., Chen, Y., Xu, X., Chen, Y., He, J., Xu, R., Gao, H., & Lu, Q. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.10.006 · Cited by 17
The role of glucagon-like peptides in osteosarcopenia
Tufail, E., Sanyal, S., Mithal, A., Sanyal, S., & Chattopadhyay, N. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0210 · Cited by 12
Frederico, M. J. S., Mascarello, A., Castro, A. J. G., da Luz, G., Altenhofen, D., Mendes, C. P., Leal, P. C., Yunes, R. A., Nunes, R. J., & Silva, F. R. M. B. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25403 · Cited by 8
“Other substances such as Glucagon Like Peptide-1 [Green et al., 2012], ursolic acid [Castro et al.”
BackgroundCarter, S., & Solomon, T. P. J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.566548 · Cited by 8
Self-citationRhabdomyolysis associated with the use of tirzepatide
Sonavane, K., Shirsat, P. D., Agrawal, G., & Agarwal, B. (2025) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2025_005392 · Cited by 6
Hagve, M., Gjessing, P. F., Hole, M. J., Jansen, K. M., Fuskevåg, O., Mollnes, T. E., Larsen, T. S., & Irtun, Ø. (2019) · Endocrinology · doi:10.1210/en.2019-00374 · Cited by 7
“The prevailing view suggests a direct effect through regulating the PI3K-Akt pathway, leading to increased glucose uptake and tissue glycogen content, as shown in cell studies and in a clamp study on GLP1-R knockout mice (14,15,56).”
BackgroundResultPhilosophe, B., Farney, A. C., Schweitzer, E. J., Colonna, J. O., Jarrell, B. E., Foster, C., Wiland, A., & Bartlett, S. T. (2000) · PubMed · Cited by 6
Mukai, R., Kojima, A., Morisasa, M., Tawara, W., Mori, T., & Goto‐Inoue, N. (2025) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbaf060 · Cited by 5
Siewe, N., & Friedman, A. (2024) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2024.111756 · Cited by 8
Katsanos, C. S., Liu, Z., & Atherton, P. J. (2026) · Comprehensive physiology · doi:10.1002/cph4.70126 · Cited by 8
“In fully differentiated human satellite cells, GLP-1 enhances glycogen synthesis along glucose uptake through a PI3K-dependent mechanism, potentially mediated by increased GLUT4 protein levels (Green et al. 2012).”
InfluentialEfek kandungan serat beras analog terhadap ekspresi GLUT4 otot rangka tikus diabetes
Darajat, A., Sakinah, E. N., & Hairrudin, H. (2019) · Jurnal Gizi Klinik Indonesia · doi:10.22146/ijcn.31806 · Cited by 5
“Glucagon like peptide-1 mengaktivasi phosphoinositide 3-kinase (PI3K) pada sel otot rangka yang dapat meningkatkan ekspresi GLUT4 sehingga terjadi peningkatan pemasukan glukosa ke dalam sel otot rangka (17).”
BackgroundPeart, L. A., Draper, M., & Tarasov, A. I. (2024) · Peptides · doi:10.1016/j.peptides.2024.171243 · Cited by 5
Yang, W., Hao, C., Wang, N., Xie, J., Zhou, B., Yang, Z., Zheng, A., Wei, J., Li, C., Xie, C., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2661854 · Cited by 3
“164,165 Additionally, GLP-1 mitigates metabolic insults in the bone marrow niche.”
Yaghmayee, S., Moazzeni, A. S., Jamialahmadi, T., Karav, S., Yaribeygi, H., Kesharwani, P., & Sahebkar, A. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.06.009 · Cited by 2
Effect of Baluran Gum Arabic on Blood Glucose Level in Diabetic Rat (Rattus Novergicus )
Wiyono, H. T., Utami, E. T., & Wardhani, D. W. P. (2021) · BERKALA SAINSTEK · doi:10.19184/bst.v9i2.22533 · Cited by 2
“Ekspresi GLUT 4 meningkat disebabkan GLP-1 mengaktivasi phospoinostide 3-kinase (PI3K) pada sel otot rangka sehingga glukosa yang masuk ke dalam sel otot rangka juga meningkat [20].”
BackgroundTajik, A., Mahdavizadeh, V., Hadizadeh, F., & Shakour, N. (2025) · Current Diabetes Reviews · doi:10.2174/0115733998349193250207045239 · Cited by 1
Falahee, B. E., Apovian, C. M., & Istfan, N. W. (2026) · Obesity · doi:10.1002/oby.70294 · Cited by 2
SUND- og SCIENCE-forskeres anvendelse af Gylden Open Access
Dorch, B. F., Børgesen, L., Knudsen, C. B., & Price, A. (2013)
Effects of Exercise on Incretin Hormones
Toghi-Eshghi, S. R. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r30g3hd88
Taher, J. (2017) · TSpace (University of Toronto) · Cited by 1
Egan, B. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733721587.793550370
Blagosklonny, M. V., & Gudkov, A. V. (2010) · Oncotarget · doi:10.18632/oncotarget.26282
Kanamarlapudi, V. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734616040.793572407
Roux-en-Y gastric bypass alters intestinal glucose transport in the obese Zucker rat
Meng, Q., Culnan, D. M., Ahmed, T., Sun, M., & Cooney, R. N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.901984 · Cited by 1
“We examined both portal venous glucose and GLP-1 levels because of the potentially important roles they play in regulating systemic glucose homeostasis (33), rapid insulin secretion (34), glucose uptake (35) and hepatic gluconeogenesis (36).”
BackgroundUtami, E. T., Fajariyah, S., Lelono, A., & Nihayah, H. (2024) · JPBIO (Jurnal Pendidikan Biologi) · doi:10.31932/jpbio.v9i1.3184 · Cited by 1
“GLUT 4 expression increases due to GLP-1 activation phosphoinostide3-kinase (PI3K) in skeletal muscle cells so that glucose entering the skeletal muscle cells also increases (Green et al., 2012)] Thus, blood sugar levels decrease.”
BackgroundMohamed, A. B. (2018) · theses.fr (ABES) · doi:10.70675/8206031dz8e5dz47a9z965az67fe5f7e19b6 · Cited by 2
Park, S.-H., Lee, Y. J., Park, S., Choi, H., Park, J., Kim, J., Baek, K., Park, K. H., & Jun, W. (2026) · Pharmaceuticals · doi:10.3390/ph19050754
“…activity of KPE has been directly demonstrated in vitro, where its major PMF constituents—3,5,7,3 ′ 4 ′ -pentamethoxyflavone and 5,7,4 ′ -trimethoxyflavone—showed potent SIRT1 enzyme-stimulating activity, supporting the mechanistic relevance of SIRT1 activation observed in the present study [33].”
Cautela, D., Valeria, I., Lombardi, A., Laratta, B., Castaldo, C. M., Balestrieri, M. L., Mocini, E., Migliaccio, S., & Tardito, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188057
“However, subsequent studies have also identified the presence of GLP-1R in skeletal muscle, although expression levels vary and are not uniformly confirmed across species and experimental models [44,47,57].”
Influential
Metadata
- Authors
- Green, C. J., Henriksen, T. I., Pedersen, B. K., & Solomon, T. P. J.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Green, Charlotte J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-08-28
- Volume
- 7
- Issue
- 8
- Pages
- e44284
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3429413
- OpenAlex
- W1984706454
- Cited by
- 80
- References
- 43
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 7 · 2018: 8 · 2017: 5 · 2016: 5 · 2015: 8 · 2014: 3 · 2013: 7
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- National Research Foundation
- European Foundation for the Study of Diabetes
- Danmarks Grundforskningsfond (# 02-512-55)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- glucagon-like peptide-1, hyperglycemia, satellite cells, skeletal muscle fibers, glucose uptake, GLUT4, GLUT1, glycogen synthesis, PI3K signaling, insulin resistance, insulin signaling, GLP-1 receptor, glucose metabolism
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Cell Differentiation, Cells, Cultured, Glucose, Glycogen, Humans, Hyperglycemia, Insulin, Male, Signal Transduction, Receptors, Glucagon, Satellite Cells, Skeletal Muscle, Cell Proliferation, Glucagon-Like Peptide 1, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.